Cell-based vaccination generally consists of autologous or allogenic whole cells, including antigen presenting cells (APCs) and PCa cells that are modified to bear TAAs and/or GM-CSF to induce anti-tumor immune responses (27). Here, CSF2 is linked to posterior cortical atrophy.